A night wind knifed across Kenya’s Great Rift Valley, carrying the sharp scent of dry acacia and cooling basalt.
High above the sheer drops of Ol Njorowa, three dark vehicles sat parked near the perimeter fence of an abandoned geothermal exploration site. Their headlights cut long, pale beams through the lingering steam that rose from underground vents.
In the rear compartment of a custom-built mobile laboratory, Amani Wanjiru sat perfectly still on a stainless-steel examination bench.
Her dark eyes were calm, but her left forearm was tender, a plastic catheter taped in place at the crook of her elbow, the surrounding skin badly bruised. Before becoming the wife of Hawthorne Vance—the billionaire founder and chief executive of Vance Global Extraction—Amani had worked as a geothermal field geologist and community land surveyor. But to European board members and Nairobi society pages, Hawthorne’s publicity team had reduced her to a quiet, unpretentious "local guide" he had married during his early surveys of the Rift.
Few knew the truth. When Hawthorne’s firm faced bankruptcy five years ago, it was Amani’s extensive fieldwork that formed the basis of the geological survey that saved his firm and guided his drilling teams towards some of the most productive geothermal reservoirs in East Africa.
"Your blood pressure is falling, Amani," said Dr Julian Cross, the chief medical officer for Sterling BioTech, as he watched the readings on the apheresis monitor. "We need another eighty millilitres of plasma to complete the validation run."
Amani looked at the clear tubing of the apheresis circuit running from her arm into a compact plasma-separation unit. Inside the collection chamber, the separated plasma held a faint golden iridescence under the fluorescent lamps—the result of a rare inherited genetic variant that allowed her body to produce an unusually stable regenerative protein found in her plasma. The inherited trait was known among clan elders as the Sun-Gazer blood.
"Eight hundred millilitres has already been collected this week, Doctor," Amani said.
Hawthorne had told her that Elena Sterling suffered from a rare marrow disorder and that Amani’s plasma might help stabilise her condition. Amani had agreed to the first extraction out of compassion. She had never agreed to hundreds of millilitres, commercial trials, or a patent transfer.
Dr Cross paused, his fingers trembling slightly over the control console. Unknown to Hawthorne, the doctor’s conscience had begun to wear thin; he had secretly backed up the raw extraction logs to an off-site server after realising Amani had never given informed consent. Before he could answer, the rear doors of the lab van hissed open, letting in a gust of cold mountain air.
Hawthorne Vance stepped inside.
He was thirty-four, broad-shouldered, and dressed in a tailored charcoal overcoat that fit his imposing height. He carried himself like a man who had never been told no. His grey eyes briefly glanced at Amani before settling on the leather-bound document in his right hand.
"Is the extraction complete?" Hawthorne asked flatly.
"We are eighty millilitres short of the minimum batch requirement, Mr Vance," Dr Cross replied.
Hawthorne pulled a silver pen from his pocket and laid the document onto the steel tray beside Amani’s knees.
"Sign the addendum, Amani," Hawthorne said.
Amani looked down at the document. Across the top, in precise corporate lettering, ran the title: **Exclusive Biological Research and Therapeutic Use Agreement.**
Below it was a clause purporting to grant Sterling BioTech exclusive commercial rights to her biological samples, associated genetic data, and any therapies or patents derived from them—a firm controlled entirely by Elena Sterling.
"This is not a medical study, Hawthorne," Amani said, her gaze lifting to meet his. "You are trying to give Elena’s company exclusive commercial rights to everything developed from my blood."
Hawthorne’s expression did not alter. "Sterling Capital has committed forty million pounds to our deep-well drilling project. In return, I have agreed to transfer control of Rift Energy Development Holdings and assign all commercial rights arising from your biological samples to Sterling BioTech. The patent assignment is a condition of the financing agreement."
"And what am I in this agreement?" Amani asked. "A donor? Or a line item on your balance sheet?"
"You are my wife," Hawthorne answered coldly. "And as my wife, your assets and legal status are tied to the stability of Vance Global. You have lived comfortably in London and Nairobi for three years. It is time to secure the firm’s future."
Amani studied him. Whatever quiet affection she had once carried for him was gone, replaced by a sobering clarity.
For three years, she had believed his emotional distance was merely the burden of a man carrying a global enterprise. She had believed that silent patience would eventually earn his respect. She saw now that she had never been a partner. She had been an uncredited asset, waiting to be liquidated.
---